Mosaic ImmunoEngineering (CPMV) Return on Assets (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Return on Assets of 0.46% for Q1 2026, down 39.0% year-over-year from 0.75% in Q1 2025, and down 150.85% quarter-over-quarter from 0.18% in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Return on Assets (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Return on Assets history runs 16 years deep, the most recent figure standing at 0.46% for Q1 2026.
- In Q1 2026, Return on Assets fell 39.0% year-over-year to 0.46%; the TTM figure through Mar 2026 stood at 0.46% (down 39.0% YoY), while the FY2025 annual figure was 0.09%, down 3.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.46%, down from 0.18% in the prior quarter.
- The five-year high for Return on Assets was 0.04% in Q3 2023, with the low at 0.46% in Q1 2026.
- The 5-year median for Return on Assets is 0.1% (2023), against an average of 0.14%.
- The sharpest annual moves came in 2025 and 2026: Return on Assets rose 29 bps in 2025, then plunged 39 bps in 2026.
- Mosaic ImmunoEngineering's Return on Assets stood at 0.07% in 2022, then jumped by 37 bps to 0.04% in 2023, then plunged by 134 bps to 0.1% in 2024, then sank by 80 bps to 0.18% in 2025, then slumped by 151 bps to 0.46% in 2026.
- Business Quant data shows CPMV's Return on Assets at 0.46% in Q1 2026, 0.18% in Q4 2025, and 0.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | -0.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.46% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | -0.09% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -0.41% |
| Jun 30, 2024 | -0.27% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.10% |
| Dec 31, 2022 | -0.07% |
| Sep 30, 2022 | -0.08% |
| Jun 30, 2022 | -0.11% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | -0.10% |
| Sep 30, 2021 | -0.07% |
| Jun 30, 2021 | -0.06% |